Product Information
PHENDIMETRAZINE 35 MG TABLET is a generic product labeled by KVK-Tech Inc., priced at $0.1320 per EA under NDC 10702007710. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Aug 31, 2010. Its Orange Book therapeutic-equivalence code is AA.
Strength
35 mg/1
Manufacturer
KVK-Tech Inc.NDC
10702007710
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PHENDIMETRAZINE TARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA091042FDA Approved
8/31/2010
TE Code
AA
On Market Since
9/15/2010
Pharmacological Classes
Price Statistics
The NADAC for PHENDIMETRAZINE 35 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 2.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1320 per EA |
|---|---|
| All-time high | $0.1650 (Apr 10, 2024) |
| All-time low | $0.1063 (May 20, 2020) |
| 52-week high | $0.1329 |
| 52-week low | $0.1247 |
| Median price | $0.1272 |
| Average price | $0.1306 |
| Largest weekly change | +32.2% (Jun 17, 2020) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 15% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
KVK-Tech Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Phendimetrazine Tartrate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sympathomimetic Amine Anorectic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PHENDIMETRAZINE 35 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PHENDIMETRAZINE 35 MG TABLET, manufactured by KVK-Tech Inc., is $0.1320 per EA (NDC 10702007710), effective Sep 30, 2026.
How has the price of PHENDIMETRAZINE 35 MG TABLET changed over time?
Over the history we have for it, the NADAC for PHENDIMETRAZINE 35 MG TABLET has risen 2.7%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PHENDIMETRAZINE 35 MG TABLET?
Since Nov 28, 2013, the NADAC for PHENDIMETRAZINE 35 MG TABLET has ranged from a low of $0.1063 (May 20, 2020) to a high of $0.1650 (Apr 10, 2024), with a median of $0.1272 per EA.
Are there cheaper alternatives to PHENDIMETRAZINE 35 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PHENDIMETRAZINE 35 MG TABLET, is $0.1119 per EA — about 15% below PHENDIMETRAZINE 35 MG TABLET.
Who manufactures PHENDIMETRAZINE 35 MG TABLET?
PHENDIMETRAZINE 35 MG TABLET (NDC 10702007710) is labeled by KVK-Tech Inc., and CMS classifies it as a generic product.